$OGEN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ORAGENICS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in ORAGENICS INC. Get notifications about new insider transactions in ORAGENICS INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 12 2014 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 3.32 | 875 | 2,905 | 73,188 | 74.1 K to 73.2 K (-1.18 %) |
Feb 28 2014 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Gift | G | 0.00 | 450,000 | 0 | 519,666 | 969.7 K to 519.7 K (-46.41 %) |
Feb 03 2014 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 6,000 | 0 | 20,000 | 14 K to 20 K (+42.86 %) |
Feb 03 2014 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 300,000 | 0 | 969,666 | 669.7 K to 969.7 K (+44.80 %) |
Feb 03 2014 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 300,000 | 0 | 592,878 | 292.9 K to 592.9 K (+102.43 %) |
Feb 03 2014 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 300,000 | 0 | 1,065,729 | 765.7 K to 1.1 M (+39.18 %) |
Feb 03 2014 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Sell | J | 0.00 | 906,000 | 0 | 8,257,742 | 9.2 M to 8.3 M (-9.89 %) |
Dec 31 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.85 | 9,200 | 26,220 | 74,063 | 83.3 K to 74.1 K (-11.05 %) |
Dec 31 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.87 | 200 | 574 | 83,263 | 83.5 K to 83.3 K (-0.24 %) |
Dec 31 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.86 | 600 | 1,716 | 83,463 | 84.1 K to 83.5 K (-0.71 %) |
Dec 26 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.90 | 3,200 | 9,280 | 84,063 | 87.3 K to 84.1 K (-3.67 %) |
Dec 26 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.90 | 100 | 290 | 87,263 | 87.4 K to 87.3 K (-0.11 %) |
Dec 26 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.91 | 400 | 1,164 | 87,363 | 87.8 K to 87.4 K (-0.46 %) |
Dec 26 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.92 | 600 | 1,752 | 87,763 | 88.4 K to 87.8 K (-0.68 %) |
Dec 26 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.93 | 700 | 2,051 | 88,363 | 89.1 K to 88.4 K (-0.79 %) |
Dec 26 2013 | OGEN | ORAGENICS INC | KIRK RANDAL J | 10% Owner | Buy | C | 2.82 | 698,241 | 1,969,040 | 8,838,666 | 8.1 M to 8.8 M (+8.58 %) |
Dec 23 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.91 | 675 | 1,964 | 89,063 | 89.7 K to 89.1 K (-0.75 %) |
Dec 23 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.85 | 4,225 | 12,041 | 89,738 | 94 K to 89.7 K (-4.50 %) |
Dec 23 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.86 | 4,800 | 13,728 | 93,963 | 98.8 K to 94 K (-4.86 %) |
Dec 23 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.86 | 300 | 858 | 98,763 | 99.1 K to 98.8 K (-0.30 %) |
Dec 20 2013 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Gift | G | 0.00 | 33,185 | 0 | 530,851 | 497.7 K to 530.9 K (+6.67 %) |
Dec 20 2013 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Gift | G | 0.00 | 33,185 | 0 | 292,878 | 326.1 K to 292.9 K (-10.18 %) |
Dec 18 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.82 | 5,000 | 14,100 | 99,063 | 104.1 K to 99.1 K (-4.80 %) |
Dec 18 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.84 | 3,900 | 11,076 | 104,063 | 108 K to 104.1 K (-3.61 %) |
Dec 18 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 2.85 | 100 | 285 | 107,963 | 108.1 K to 108 K (-0.09 %) |
Dec 13 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 3.00 | 4,000 | 12,000 | 108,063 | 112.1 K to 108.1 K (-3.57 %) |
Dec 13 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 3.00 | 3,000 | 9,000 | 112,063 | 115.1 K to 112.1 K (-2.61 %) |
Dec 11 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 3.03 | 3,000 | 9,090 | 115,063 | 118.1 K to 115.1 K (-2.54 %) |
Dec 11 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 3.00 | 1,500 | 4,500 | 118,063 | 119.6 K to 118.1 K (-1.25 %) |
Dec 11 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Sell | S | 3.11 | 1,500 | 4,665 | 119,563 | 121.1 K to 119.6 K (-1.24 %) |
Dec 04 2013 | OGEN | ORAGENICS INC | POPE CHARLES L | Director | Sell | S | 3.10 | 5,000 | 15,498 | 111,063 | 116.1 K to 111.1 K (-4.31 %) |
Dec 04 2013 | OGEN | ORAGENICS INC | POPE CHARLES L | Director | Sell | S | 3.13 | 5,000 | 15,650 | 116,063 | 121.1 K to 116.1 K (-4.13 %) |
Dec 02 2013 | OGEN | ORAGENICS INC | Sullivan Michael O'Keefe | CFO, Secretary and ... | Payment of Exercise | F | 3.00 | 26,795 | 80,385 | 142,543 | 169.3 K to 142.5 K (-15.82 %) |
Dec 02 2013 | OGEN | ORAGENICS INC | Sullivan Michael O'Keefe | CFO, Secretary and ... | Grant | A | 0.00 | 76,795 | 0 | 169,338 | 92.5 K to 169.3 K (+82.98 %) |
Dec 02 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Grant | A | 0.00 | 38,397 | 0 | 121,063 | 82.7 K to 121.1 K (+46.45 %) |
Dec 02 2013 | OGEN | ORAGENICS INC | Telling Fred | Director | Grant | A | 0.00 | 38,397 | 0 | 229,174 | 190.8 K to 229.2 K (+20.13 %) |
Dec 02 2013 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Grant | A | 0.00 | 38,397 | 0 | 765,729 | 727.3 K to 765.7 K (+5.28 %) |
Dec 02 2013 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Grant | A | 0.00 | 38,397 | 0 | 326,063 | 287.7 K to 326.1 K (+13.35 %) |
Dec 02 2013 | OGEN | ORAGENICS INC | POPE CHARLES L | Director | Grant | A | 0.00 | 38,397 | 0 | 121,063 | 82.7 K to 121.1 K (+46.45 %) |
Dec 02 2013 | OGEN | ORAGENICS INC | BONFIGLIO JOHN N | President and CEO | Payment of Exercise | F | 3.00 | 60,000 | 180,000 | 384,255 | 444.3 K to 384.3 K (-13.51 %) |
Dec 02 2013 | OGEN | ORAGENICS INC | BONFIGLIO JOHN N | President and CEO | Grant | A | 0.00 | 174,533 | 0 | 444,255 | 269.7 K to 444.3 K (+64.71 %) |
Nov 22 2013 | OGEN | ORAGENICS INC | KIRK RANDAL J | 10% Owner | Buy | P | 2.50 | 1,099,490 | 2,748,725 | 8,140,425 | 7 M to 8.1 M (+15.62 %) |
Nov 22 2013 | OGEN | ORAGENICS INC | KIRK RANDAL J | 10% Owner | Buy | P | 2.50 | 143,000 | 357,500 | 1,000,555 | 857.6 K to 1 M (+16.68 %) |
Oct 22 2013 | OGEN | ORAGENICS INC | BONFIGLIO JOHN N | President and CEO | Payment of Exercise | F | 2.99 | 50,000 | 149,500 | 269,722 | 319.7 K to 269.7 K (-15.64 %) |
Oct 22 2013 | OGEN | ORAGENICS INC | BONFIGLIO JOHN N | President and CEO | Grant | A | 0.00 | 150,843 | 0 | 319,722 | 168.9 K to 319.7 K (+89.32 %) |
Oct 22 2013 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Grant | A | 0.00 | 33,185 | 0 | 727,332 | 694.1 K to 727.3 K (+4.78 %) |
Oct 22 2013 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Grant | A | 0.00 | 33,185 | 0 | 287,666 | 254.5 K to 287.7 K (+13.04 %) |
Oct 22 2013 | OGEN | ORAGENICS INC | Sullivan Michael O'Keefe | CFO, Secretary and ... | Payment of Exercise | F | 2.99 | 19,000 | 56,810 | 92,543 | 111.5 K to 92.5 K (-17.03 %) |
Oct 22 2013 | OGEN | ORAGENICS INC | Sullivan Michael O'Keefe | CFO, Secretary and ... | Grant | A | 0.00 | 54,304 | 0 | 111,543 | 57.2 K to 111.5 K (+94.87 %) |
Oct 22 2013 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Grant | A | 0.00 | 33,185 | 0 | 82,666 | 49.5 K to 82.7 K (+67.07 %) |
Oct 22 2013 | OGEN | ORAGENICS INC | Telling Fred | Director | Grant | A | 0.00 | 33,185 | 0 | 190,777 | 157.6 K to 190.8 K (+21.06 %) |
Oct 22 2013 | OGEN | ORAGENICS INC | POPE CHARLES L | Director | Grant | A | 0.00 | 33,185 | 0 | 82,666 | 49.5 K to 82.7 K (+67.07 %) |
Oct 11 2013 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 4,000 | 0 | 14,000 | 10 K to 14 K (+40.00 %) |
Oct 11 2013 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 200,000 | 0 | 669,666 | 469.7 K to 669.7 K (+42.58 %) |
Oct 11 2013 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 200,000 | 0 | 254,481 | 54.5 K to 254.5 K (+367.10 %) |
Oct 11 2013 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 200,000 | 0 | 694,147 | 494.1 K to 694.1 K (+40.47 %) |
Oct 11 2013 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Sell | J | 0.00 | 604,000 | 0 | 9,163,742 | 9.8 M to 9.2 M (-6.18 %) |
Oct 02 2013 | OGEN | ORAGENICS INC | KIRK RANDAL J | 10% Owner | Buy | P | 3.00 | 2,648,510 | 7,945,530 | 7,040,935 | 4.4 M to 7 M (+60.30 %) |
Oct 25 2012 | OGEN | ORAGENICS INC | Telling Fred | Director | Grant | A | 0.00 | 13,081 | 0 | 157,592 | 144.5 K to 157.6 K (+9.05 %) |
Oct 25 2012 | OGEN | ORAGENICS INC | BONFIGLIO JOHN N | President and CEO | Payment of Exercise | F | 2.10 | 14,939 | 31,372 | 168,879 | 183.8 K to 168.9 K (-8.13 %) |
Oct 25 2012 | OGEN | ORAGENICS INC | BONFIGLIO JOHN N | President and CEO | Grant | A | 0.00 | 56,482 | 0 | 183,818 | 127.3 K to 183.8 K (+44.36 %) |
Oct 25 2012 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Grant | A | 0.00 | 13,081 | 0 | 49,481 | 36.4 K to 49.5 K (+35.94 %) |
Oct 25 2012 | OGEN | ORAGENICS INC | POPE CHARLES L | Director | Grant | A | 0.00 | 13,081 | 0 | 49,481 | 36.4 K to 49.5 K (+35.94 %) |
Oct 25 2012 | OGEN | ORAGENICS INC | Sullivan Michael O'Keefe | CFO, Secretary and ... | Payment of Exercise | F | 2.10 | 26,261 | 55,148 | 57,239 | 83.5 K to 57.2 K (-31.45 %) |
Oct 25 2012 | OGEN | ORAGENICS INC | Sullivan Michael O'Keefe | CFO, Secretary and ... | Grant | A | 0.00 | 83,500 | 0 | 83,500 | 0 to 83.5 K |
Oct 25 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Grant | A | 0.00 | 13,081 | 0 | 494,147 | 481.1 K to 494.1 K (+2.72 %) |
Oct 25 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Grant | A | 0.00 | 13,081 | 0 | 54,481 | 41.4 K to 54.5 K (+31.60 %) |
Oct 19 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Option Exercise | G | 2.00 | 500,000 | 1,000,000 | 500,000 | |
Oct 19 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Option Exercise | G | 2.00 | 500,000 | 1,000,000 | 0 | |
Oct 19 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Option Exercise | J | 2.00 | 10,000 | 20,000 | 10,000 | |
Oct 19 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Option Exercise | J | 2.00 | 500,000 | 1,000,000 | 500,000 | |
Oct 19 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Option Exercise | J | 2.00 | 500,000 | 1,000,000 | 500,000 | |
Oct 19 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Option Exercise | J | 2.00 | 500,000 | 1,000,000 | 500,000 | |
Oct 19 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Option Exercise | J | 2.00 | 1,510,000 | 3,020,000 | 660,925 | |
Aug 08 2012 | OGEN | ORAGENICS INC | Telling Fred | Director | Grant | A | 0.00 | 30,000 | 0 | 144,511 | 114.5 K to 144.5 K (+26.20 %) |
Aug 08 2012 | OGEN | ORAGENICS INC | POPE CHARLES L | Director | Grant | A | 0.00 | 30,000 | 0 | 36,400 | 6.4 K to 36.4 K (+468.75 %) |
Aug 08 2012 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Grant | A | 0.00 | 30,000 | 0 | 36,400 | 6.4 K to 36.4 K (+468.75 %) |
Aug 08 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Grant | A | 0.00 | 30,000 | 0 | 481,066 | 451.1 K to 481.1 K (+6.65 %) |
Aug 08 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Grant | A | 0.00 | 30,000 | 0 | 41,400 | 11.4 K to 41.4 K (+263.16 %) |
Aug 08 2012 | OGEN | ORAGENICS INC | BONFIGLIO JOHN N | President and CEO | Payment of Exercise | F | 2.75 | 34,914 | 96,014 | 127,336 | 162.3 K to 127.3 K (-21.52 %) |
Aug 08 2012 | OGEN | ORAGENICS INC | BONFIGLIO JOHN N | President and CEO | Grant | A | 0.00 | 132,000 | 0 | 162,250 | 30.3 K to 162.3 K (+436.36 %) |
Aug 02 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | P | 1.50 | 1,692,123 | 2,538,185 | 9,767,742 | 8.1 M to 9.8 M (+20.95 %) |
Aug 02 2012 | OGEN | ORAGENICS INC | Telling Fred | Director | Buy | P | 1.50 | 98,111 | 147,167 | 114,511 | 16.4 K to 114.5 K (+598.24 %) |
Aug 02 2012 | OGEN | ORAGENICS INC | KIRK RANDAL J | 10% Owner | Buy | P | 1.50 | 857,555 | 1,286,333 | 857,555 | 0 to 857.6 K |
Mar 27 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Option Exercise | P | 2.00 | 599,520 | 1,199,040 | 599,520 | |
Mar 27 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Option Exercise | P | 2.00 | 1,571,405 | 3,142,810 | 1,571,405 | |
Mar 27 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | P | 0.00 | 6,285,619 | 0 | 8,075,619 | 1.8 M to 8.1 M (+351.15 %) |
Feb 14 2012 | OGEN | ORAGENICS INC | Sullivan Michael O'Keefe | CFO, Secretary and ... | Option Exercise | A | 1.20 | 45,000 | 54,000 | 45,000 | |
Feb 06 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Gift | G | 0.00 | 427,666 | 0 | 497,666 | 70 K to 497.7 K (+610.95 %) |
Feb 06 2012 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Gift | G | 0.00 | 427,666 | 0 | 11,400 | 439.1 K to 11.4 K (-97.40 %) |
Nov 16 2011 | OGEN | ORAGENICS INC | BONFIGLIO JOHN N | President and CEO | Grant | A | 0.00 | 29,000 | 0 | 30,250 | 1.3 K to 30.3 K (+2,320.00 %) |
Nov 16 2011 | OGEN | ORAGENICS INC | Bohunicky Brian John | CFO, Secretary and ... | Grant | A | 0.00 | 12,800 | 0 | 37,800 | 25 K to 37.8 K (+51.20 %) |
Nov 16 2011 | OGEN | ORAGENICS INC | Telling Fred | Director | Grant | A | 0.00 | 6,400 | 0 | 16,400 | 10 K to 16.4 K (+64.00 %) |
Nov 16 2011 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Grant | A | 0.00 | 6,400 | 0 | 6,400 | 0 to 6.4 K |
Nov 16 2011 | OGEN | ORAGENICS INC | POPE CHARLES L | Director | Grant | A | 0.00 | 6,400 | 0 | 6,400 | 0 to 6.4 K |
Oct 14 2011 | OGEN | ORAGENICS INC | HILLMAN JEFFREY D | Chief Scientific Of ... | Grant | A | 0.00 | 120,000 | 0 | 159,283 | 39.3 K to 159.3 K (+305.48 %) |
Nov 16 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Grant | A | 0.00 | 6,400 | 0 | 451,066 | 444.7 K to 451.1 K (+1.44 %) |
Nov 16 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Grant | A | 0.00 | 6,400 | 0 | 439,066 | 432.7 K to 439.1 K (+1.48 %) |
Sep 30 2011 | OGEN | ORAGENICS INC | Bohunicky Brian John | CFO, Secretary and ... | Option Exercise | A | 1.50 | 28,000 | 42,000 | 28,000 | |
Sep 30 2011 | OGEN | ORAGENICS INC | BONFIGLIO JOHN N | President and CEO | Option Exercise | A | 1.50 | 39,200 | 58,800 | 39,200 | |
Aug 29 2011 | OGEN | ORAGENICS INC | Telling Fred | Director | Buy | P | 2.39 | 6,460 | 15,439 | 10,000 | 3.5 K to 10 K (+182.49 %) |
Aug 24 2011 | OGEN | ORAGENICS INC | Telling Fred | Director | Buy | P | 2.29 | 2,540 | 5,817 | 3,540 | 1,000 to 3.5 K (+254.00 %) |
Aug 24 2011 | OGEN | ORAGENICS INC | Telling Fred | Director | Buy | P | 2.20 | 1,000 | 2,200 | 1,000 | 0 to 1,000 |
Aug 19 2011 | OGEN | ORAGENICS INC | Bohunicky Brian John | CFO, Secretary and ... | Buy | P | 2.15 | 2,500 | 5,375 | 25,000 | 22.5 K to 25 K (+11.11 %) |
Aug 16 2011 | OGEN | ORAGENICS INC | BONFIGLIO JOHN N | President and CEO | Buy | P | 2.15 | 1,250 | 2,688 | 1,250 | 0 to 1.3 K |
May 26 2011 | OGEN | ORAGENICS INC | BONFIGLIO JOHN N | President and CEO | Option Exercise | A | 4.76 | 125,800 | 598,808 | 125,800 | |
May 17 2011 | OGEN | ORAGENICS INC | Telling Fred | Director | Option Exercise | A | 5.00 | 50,000 | 250,000 | 50,000 | |
May 17 2011 | OGEN | ORAGENICS INC | POPE CHARLES L | Director | Option Exercise | A | 5.00 | 50,000 | 250,000 | 50,000 | |
May 17 2011 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Option Exercise | A | 5.00 | 50,000 | 250,000 | 50,000 | |
Apr 04 2011 | OGEN | ORAGENICS INC | DUNTON ALAN W | Director | Option Exercise | A | 3.30 | 5,000 | 16,500 | 5,000 | |
Mar 15 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Grant | A | 0.00 | 10,000 | 0 | 432,666 | 422.7 K to 432.7 K (+2.37 %) |
Mar 15 2011 | OGEN | ORAGENICS INC | Bohunicky Brian John | CFO, Secretary and ... | Option Exercise | A | 3.60 | 20,000 | 72,000 | 20,000 | |
Mar 15 2011 | OGEN | ORAGENICS INC | Bohunicky Brian John | CFO, Secretary and ... | Grant | A | 0.00 | 10,000 | 0 | 22,500 | 12.5 K to 22.5 K (+80.00 %) |
Feb 15 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 8,000 | 0 | 10,000 | 2 K to 10 K (+400.00 %) |
Feb 15 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 400,000 | 0 | 469,666 | 69.7 K to 469.7 K (+574.17 %) |
Feb 15 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 400,000 | 0 | 422,666 | 22.7 K to 422.7 K (+1,764.76 %) |
Feb 15 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 400,000 | 0 | 444,666 | 44.7 K to 444.7 K (+895.54 %) |
Feb 15 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Sell | J | 0.00 | 1,208,000 | 0 | 1,790,000 | 3 M to 1.8 M (-40.29 %) |
Feb 15 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 8,000 | 0 | 10,000 | 2 K to 10 K (+400.00 %) |
Feb 15 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 400,000 | 0 | 469,666 | 69.7 K to 469.7 K (+574.17 %) |
Feb 15 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 400,000 | 0 | 422,666 | 22.7 K to 422.7 K (+1,764.76 %) |
Feb 15 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | J | 0.00 | 400,000 | 0 | 444,666 | 44.7 K to 444.7 K (+895.54 %) |
Feb 15 2011 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Sell | J | 0.00 | 1,208,000 | 0 | 1,790,000 | 3 M to 1.8 M (-40.29 %) |
Oct 18 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | D | 8.50 | 1,000 | 8,500 | 539,397 | 540.4 K to 539.4 K (-0.19 %) |
Oct 12 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | D | 8.00 | 1,215 | 9,720 | 540,397 | 541.6 K to 540.4 K (-0.22 %) |
Aug 11 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.35 | 40,000 | 14,000 | 10,857,235 | 10.9 M to 10.9 M (-0.37 %) |
Aug 11 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.34 | 25,000 | 8,500 | 10,897,235 | 10.9 M to 10.9 M (-0.23 %) |
Aug 26 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | D | 0.31 | 25,000 | 7,650 | 10,832,235 | 10.9 M to 10.8 M (-0.23 %) |
Aug 03 2010 | OGEN | ORAGENICS INC | KOSKI FAMILY LP | 10% Owner | Buy | P | 0.40 | 5,000,000 | 2,000,000 | 59,960,000 | 55 M to 60 M (+9.10 %) |
Aug 04 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.34 | 10,000 | 3,400 | 10,922,235 | 10.9 M to 10.9 M (-0.09 %) |
Aug 04 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.35 | 52,800 | 18,216 | 10,932,235 | 11 M to 10.9 M (-0.48 %) |
Aug 04 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.35 | 40,000 | 14,000 | 10,985,035 | 11 M to 11 M (-0.36 %) |
Jul 09 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.38 | 5,000 | 1,900 | 11,025,035 | 11 M to 11 M (-0.05 %) |
Jul 09 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.35 | 80,000 | 28,000 | 11,030,035 | 11.1 M to 11 M (-0.72 %) |
Jun 25 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.42 | 6,935 | 2,913 | 11,110,035 | 11.1 M to 11.1 M (-0.06 %) |
Jun 18 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.42 | 73,000 | 30,660 | 11,120,970 | 11.2 M to 11.1 M (-0.65 %) |
Jun 18 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.42 | 30,000 | 12,600 | 11,193,970 | 11.2 M to 11.2 M (-0.27 %) |
Jun 21 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.47 | 4,000 | 1,880 | 11,116,970 | 11.1 M to 11.1 M (-0.04 %) |
Jun 10 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 484.00 | 8,150 | 3,944,600 | 11,223,970 | 11.2 M to 11.2 M (-0.07 %) |
Jun 08 2010 | OGEN | ORAGENICS INC | POPE CHARLES L | Director | Option Exercise | A | 0.50 | 100,000 | 50,000 | 100,000 | |
Jun 08 2010 | OGEN | ORAGENICS INC | Telling Fred | Director | Option Exercise | A | 0.50 | 100,000 | 50,000 | 100,000 | |
Jun 07 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.49 | 16,000 | 7,840 | 11,232,120 | 11.2 M to 11.2 M (-0.14 %) |
Jun 07 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.51 | 19,225 | 9,747 | 11,248,120 | 11.3 M to 11.2 M (-0.17 %) |
May 06 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.70 | 20,000 | 14,000 | 11,267,345 | 11.3 M to 11.3 M (-0.18 %) |
Apr 15 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Buy | S | 0.70 | 45,500 | 31,850 | 11,287,345 | 11.2 M to 11.3 M (+0.40 %) |
Apr 12 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.70 | 50,000 | 35,000 | 11,333,122 | 11.4 M to 11.3 M (-0.44 %) |
Apr 12 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.61 | 20,000 | 12,200 | 11,383,122 | 11.4 M to 11.4 M (-0.18 %) |
Apr 12 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.62 | 40,700 | 25,234 | 11,403,122 | 11.4 M to 11.4 M (-0.36 %) |
Apr 12 2010 | OGEN | ORAGENICS INC | HAWES GEORGE T | 10% Owner | Sell | S | 0.59 | 40,000 | 23,600 | 11,443,822 | 11.5 M to 11.4 M (-0.35 %) |
Mar 02 2010 | OGEN | ORAGENICS INC | HILLMAN JEFFREY D | Chief Scientific Of ... | Gift | G | 0.00 | 6,350 | 0 | 785,664 | 792 K to 785.7 K (-0.80 %) |